Литература
1. Global Initiative for Asthma. Global Str ategy for Asthma Management and Prevention, 2018. (дата обращения: 29 июня 2019 г.)
URL: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf
2. Mallol J., Crane J., Mutius von E. et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis // Allergol. Immunopathol. (Madr.). 2013. Vol. 41, N 2. P. 73-85.
3. Soto-Martínez M.E., Yock-Corrales A., Camacho-Badilla K. et al. The current prevalence of asthma, allergic rhinitis, and eczema related symptoms in school-aged children in Costa Rica // J Asthma. 2018. Vol. 25. P. 1-9.
4. Батожаргалова Б.Ц., Мизерницкий, Ю.Л., Подольная М.А. Метаанализ распространенности астмоподобных симптомов и бронхиальнойастмы в России (по результатам программы ISAAC) // Рос. вестн. перинатол. и педиатр. 2016. № 61 (4). C. 59-69.
5. Zysman-Colman Z., Tremblay G.M., Bandeali S. et al. Bronchopulmonary dysplasia-trends over three decades // Pediatr. Child Health. 2013. Vol. 18. P. 86-90.
6. Anvekar A.P., Shah P.S., Nathan E.A. et al. High frequency jet ventilation in preterm infants: experience from Western Australia // J. Matern. Fetal Neonatal Med. 2019. Vol. 32, N 17. P 2824-2829.
7. Roberts D., Brown J., Medley N., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth // Cochrane Database Syst. Rev. 2017. Vol. 3. CD004454. (дата обращения: 29 июня 2019 г.)
URL: www.ncbi.nlm.nih.gov/pmc/articles/PMC6464568/
doi: 10.1002/14651858.CD004454.pub3
8. Seger N., Soil R. Animal derived surfactant extract for treatment of respiratory distress syndrome // Cochrane Database Syst. Rev. 2009. Vol. 2. CD007836 (дата обращения: 29 июня 2019 г.)
URL: https://pubmed.ncbi.nlm.nih.gov/19370695-animal-derived-surfactant-extract-for-treatment-of-respiratory-distress-syndrome/
doi: 10.1002/14651858.CD007836
9. Stoll B.J., Hansen N.I., Bell E.F. et al. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network // Pediatrics. 2010. Vol. 126. P 443-456.
10. Day C.L., Ryan R.M. Bronchopulmonary dysplasia: old becomes new again! // Pediatr. Res. 2016. Vol. 81, N 1-2. P 210-213.
11. Latini G., De Felice C., Giannuzzi R. et al. Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants // Early Hum. Dev. 2013. Vol. 89. P S69-S73.
12. Lapcharoensap W., Gage S.C., Kan P et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort // JAMA Pediatr. 2015. Vol. 169. Article ID e143676.
13. Nickerson B.G., Taussig L.M. Family history of asthma in infants with bronchopulmonary dysplasia // Pediatrics. 1980. Vol. 65. P 1140.
14. Овсянников Д.Ю., Бойцова Е.В., Давыдова И.В., и др. Бронхолегочная дисплазия: от Норсвея до наших дней / под ред. Д.Ю. Овсянникова. М. : РУДН, 2016. 384 с.
15. Кузьмина Т.Б. Прогнозирование бронхолегочных заболеваний в раннем возрасте у детей, находившихся на искусственной вентиляции легких в неонатальном периоде : автореф. дис. ... канд. мед. наук. М., 1996.
16. Балаболкин И.И., Булгакова В.А. Бронхиальная астма у детей. M. : МИА, 2015. 144 с.
17. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2014. (дата обращения: 29 июня 2019 г.)
URL: www.doctorbeketov.ru/data/documents/Bronhialnaya-astma-GYNA-2014-russkaya-versiya.pdf
18. Национальная программа: Бронхиальная астма у детей. Стратегия лечения и профилактики. 4-е изд., перераб. и доп. М. : Оригиналмакет, 2012. 184 с.
19. Doyle L.W., Cheung M.M.H., Ford G.W. et al. Birth weight <1501 g and respiratory health at age 14 // Arch. Dis. Child. 2001. Vol. 84. P. 40-44.
20. Hung Y.L., Hsieh W.S., Chou H.C. et al. Very low birth weight infants with bronchopulmonary dysplasia have higher risk to develop childhood asthma // Clin. Neonatol. 2005. Vol. 12, N 2. P 45-50.
21. Пятеркина О.Г., ШагиахметоваД.С., Храмова Л.В. и др. Течение и исходы бронхолегочной дисплазии у детей в Республике Татарстан // Сборник трудов конгресса "XIX Национальный конгресс по болезням органов дыхания". М., 2009. С. 95.
22. Запевалова Е.Ю., Клюхина Ю.Б., Бойцова Е.В. и др. Клиническое течение и структурные изменения легочной ткани у детей с бронхолегочной дисплазией в анамнезе // Педиатр. 2016. № 1 (7). С. 50-57.
23. Шабалов Н.П. Неонатология Т. 1. М. : МЕДпресс-информ, 2004. 608 с.
24. Cutz E., Chiasson D. Chronic lung disease after premature birth // N. Engl. J. Med. 2008. Vol. 358, N 7. P 743.
25. Геппе Н.А., Розинова Н.Н., Волков И.К., Мизерницкий Ю.Л. Классификация клинических форм бронхолегочных заболеваний у детей. М. : Российское респираторное общество, 2009. 18 с.
26. Bacharier L.B., Boner A., Carlsen K.H. et al.; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRAC-TALL consensus report // Allergy. 2008. Vol. 63, N 1. P. 5-34.
27. Halvorsen T., Skadberg B.T., Eide G.E. et al. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study // Acta Paediatr. 2004. Vol. 93. P 1294-1300.
28. Gongalves E.S., Mezzacappa-Filho F., Severino S.D. et al. Association between clinical variables related to asthma in schoolchildren born with very low birth weight with and without bronchopulmonary dysplasia // Rev. Paul. Pediatr. 2016. Vol. 34, N 3. P 271-280.
29. Schaubel D., Johansen H., Dutta M. et al. Neonatal characteristics as risk factors for preschool asthma // J. Asthma. 1996. Vol. 33. P 255-264.
30. Brostrom E.B., Thunqvist P., Adenfelt G. et al. Obstructive lung disease in children with mild to severe BPD // Respir. Med. 2010. Vol. 104. P. 362-370.
31. Брыксина Е.Ю. Клинико-патогенетическое значение микроаспирации желудочного содержимого в развитии и течении бронхолегочной дисплазии : автореф. дис. ... д-ра мед. наук. Воронеж, 2015.
32. Старевская С.В. Роль бронхоскопии в комплексном обследовании и лечении детей с заболеваниями легких, осложненных дыхательной недостаточностью : автореф. дис. ... д-ра мед. наук. СПб., 2016.
33. Давыдова И.В. Формирование, течение и исходы бронхолегочной дисплазии у детей : автореф. дис. ... д-ра мед. наук. М., 2010.
34. Затолокина А.О., Белоусова Т.В., Лоскутова С.А., Андрюшина И.В. Функциональные последствия бронхолегочной дисплазии у детей, проживающих на территории Новосибирской области // Мать и дитя. 2016. № 3 (66). С. 9-14.
35. Unal S., Kaya A., Bilgin L. et al. Wheezing, asthma, and atopy in premature infants at 2 years of age // Med. Sci. 2017. Vol. 47, N 2. P 607-613.
36. Ng D.K., Lau W.Y., Lee S.L. Pulmonary sequelae in long-term survivors of bronchopulmonary dysplasia // Pediatr. Int. 2000. Vol. 42. P 603607.
37. Evans M., Palta M., Sadek M. et al. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children // Am. J. Epidemiol. 1998. Vol. 148. P 460-466.
38. Софронова Л.Н., Федорова Л.А., Кянксеп А.Н. и др. Поздние недоношенные - группа высокого риска ранних и отдаленных осложнений // Педиатрия. 2018. № 1 (97). С. 131-140.
39. Guimaraes H., Rocha G., Pissara S. et al. Respiratory outcomes and atopy in school-age children who were preterm at birth, with and without bronchopulmonary dysplasia // Clinics. 2011. Vol. 66. P 425-430.
40. Kaplan E., Bar-Yishay E., Prais D. et al. Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the post-surfactant era // Chest. 2012. Vol. 142. P 725-733.
41. Bousquet J., Khaltaev N., Cruz A. et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update // Allergy. 2008. Vol. 63, N 86. P. 8-160.
42. Национальная программа "Бронхиальная астма у детей. Стратегия лечения и профилактика". 2-е изд. М. : Русский врач, 2006. 100 с.
43. Федеральные клинические рекомендации по ведению детей с бронхолегочной дисплазией, 2014. (дата обращения: 29 июня 2019 г.)
URL: https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/_kr_bld.pdf
44. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease // Nat. Rev. Immunol. 2008. Vol. 8, N 3. P 183-192.
45. Hay D.W. Pharmacology of leukotriene receptor antagonists // Chest. 1997. Vol. 111, N 2. Suppl. P. 35S-45S.
46. Szefler S., Carlsson L.G., Szefler T.U. et al. Budesonide inhalation suspension versus Montelukast in children aged 2 to 4 years with mild persistent asthma // J. Allergy Clin. Immunol. 2013. Vol. 1. P 58-64.
47. Castro-Rodriguez J.A., Rodrigo G.J. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis // Arch. Dis. Child. 2010. Vol. 95. P. 365-370.
48. Meer S., Groothuis J.R., Harbeck R. et al. The potential role of gastroesophageal reflux in the pathogenesis of food-induced wheezing // Pediatr. Allergy Immunol. 1996. Vol. 7. P 167-170.
49. Yang J.Y., Cha J., Shim S.-Y. et al. The relationship between eosino-philia and bronchopulmonary dysplasia in premature infants at less than 34 weeks’ gestation // Korean J. Pediatr. 2014. Vol. 57, N 4. P 171-177.
50. Yen J.-M., Lin C.-H., Yang M.-M. Eosinophilia in very low birth weight infants // Pediatr. Neonatol. 2010. Vol. 51, N 2. P 116-123.
51. Корженкова М.П. Клиническая характеристика и некоторые вопросы патогенеза острых респираторных заболеваний у детей первого года жизни : автореф. дис. . канд. мед. наук. М., 1969.
52. Яковлева Н.В. Респираторные вирусы. Механизмы воспаления бронхов и легких и противовоспалительная терапия. СПб. : Нордмед-Издат, 1998. 66 с.
53. Бойцова Е.В., Титова ОН., Овсянников ДЮ., Богданова А.В. Респираторные последствия бронхолегочной дисплазии у детей, подростков и взрослых // Пульмонология. 2017 № 27 (1). С. 87-96.
References
1. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2018. URL: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf (date of access June 29, 2019)
2. Mallol J., Crane J., Mutius von E., et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr). 2013; 41 (2): 73-85.
3. Soto-Martfnez M.E., Yock-Corrales A., Camacho-Badilla K., et al. The current prevalence of asthma, allergic rhinitis, and eczema related symptoms in school-aged children in Costa Rica. J. Asthma. 2018; 25: 1-9.
4. Batozhargalova B.T., Mizernitsky Y.L., Podolnaya M.A. Meta-analysis of the prevalence of asthma-like symptoms and asthma in Russia (according to the results of ISAAC). Rossiyskiy vestnik perinatologii i pediatrii [Russian Bulletin of Perinatology and Pediatrics]. 2016; 61 (4): 59-69. (in Russian)
5. Zysman-Colman Z., Tremblay G.M., Bandeali S., et al. Bronchopulmonary dysplasia-trends over three decades. Pediatr Child Health. 2013; 18: 86-90.
6. Anvekar A.P., Shah P.S., Nathan E.A., et al. High frequency jet ventilation in preterm infants: experience from Western Australia. J Matern Fetal Neonatal Med. 2019; 32 (17): 2824-9.
7. Roberts D., Brown J., Medley N., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017; 3: CD004454. (date of access June 29, 2019)
URL: www.ncbi.nlm.nih.gov/pmc/articles/PMC6464568/
doi: 10.1002/14651858.CD004454.pub3
8. Seger N., Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009; 2: CD007836. (date of access June 29, 2019)
URL: https://pubmed.ncbi.nlm.nih.gov/19370695-animal-derived-surfactant-extract-for-treatment-of-respiratory-distress-syndrome/
doi: 10.1002/14651858.CD007836
9. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network. Pediatrics. 2010; 126: 443-56.
10. Day C.L., Ryan R.M. Bronchopulmonary dysplasia: old becomes new again! Pediatr Res. 2016; 81 (1-2): 210-3.
11. Latini G., De Felice C., Giannuzzi R., et al. Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants. Early Hum Dev. 2013; 89: S69-73.
12. Lapcharoensap W., Gage S.C., Kan P., et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015; 169: e143676.
13. Nickerson B.G., Taussig L.M. Family history of asthma in infants with bronchopulmonary dysplasia. Pediatrics. 1980; 65: 1140.
14. Ovsyannikov D.Yu., Bojczova E.V., Davy'dova I.V., et al. Bronchopulmonary dysplasia: from Northway to the present day. Edited by D.Yu. Ovsyannikov. Moscow: RUDN, 2016: 384 p. (in Russian)
15. Kuz’mina T.B. Prediction of bronchopulmonary diseases at an early age in children who were on artificial ventilation in the neonatal period: Au-toabstact of Diss. Moscow, 1996. (in Russian)
16. Balabolkin I.I., Bulgakova V.A. Bronchial asthma in children. Moscow: MIA, 2015: 144 р. (in Russian)
17. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2014. URL: http://www.doctorbeketov.ru/data/documents/ Bronhialnaya-astma-GYNA-2014-russkaya-versiya.pdf (date of access June 29, 2019)
18. National program: "Bronchial asthma in children. Treatment and Prevention Strategy". 4th ed., revised and additional. Moscow: Original-maket, 2012: 184 р. (in Russian)
19. Doyle L.W., Cheung M.M.H., Ford G.W., et al. Birth weight <1501 g and respiratory health at age 14. Arch Dis Child. 2001; 84: 40-4.
20. Hung Y.L., Hsieh W.S., Chou H.C., et al. Very low birth weight infants with bronchopulmonary dysplasia have higher risk to develop childhood asthma. Clin Neonatol. 2005; 12 (2): 45-50.
21. Pyaterkina O.G., SHagiahmetova D.S., Hramova L.V., et al. Course and outcomes of bronchopulmonary dysplasia in children in the Republic of Tatarstan. In: Sbornik trudov kongressa. "XIX Natsional’nyy kongress po boleznyam organov dyhaniya" [Proceedings Congress works "XIX National Congress on Respiratory Diseases"]. Moscow, 2009: 95. (in Russian)
22. Zapevalova E.Yu., Klyukhina Yu.B., Boitsova E.V., et al. Clinical current and structural changes of pulmonary tissue at children with a bronchopulmonary dysplasia in the anamnesis. Pediatr [Pediatrician]. 2016; 1 (7): 50-7. (in Russian)
23. Shabalov N.P. Neonatology. Vol. 1. Moscow: MEDpress-inform, 2004: 608 p. (in Russian)
24. Cutz E., Chiasson D. Chronic lung disease after premature birth. N Engl J Med. 2008; 358 (7): 743.
25. Geppe N.A., Rozinova N.N., Volkov I.K., Mizernickiy Yu.L. Classification of the clinical forms of bronchopulmonary diseases in children. Moscow: Rossiyskoe respiratornoe obshchestvo, 2009: 18 p. (in Russian)
26. Bacharier L.B., Boner A., Carlsen K.H., et al.; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008; 63 (1): 5-34.
27. Halvorsen T., Skadberg B.T., Eide G.E., et al. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr. 2004; 93: 1294-300.
28. Gongalves E.S., Mezzacappa-Filho F., Severino S.D., et al. Association between clinical variables related to asthma in schoolchildren born with very low birth weight with and without bronchopulmonary dysplasia. Rev Paul Pediatr. 2016; 34 (3): 271-80.
29. Schaubel D., Johansen H., Dutta M., et al. Neonatal characteristics as risk factors for preschool asthma. J Asthma. 1996; 33: 255-64.
30. Brostrom E.B., Thunqvist P., Adenfelt G., et al. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010; 104: 362-70.
31. Bryksina E.Yu. Clinical and pathogenic relevance of gastric contents microaspiration in the onset and course of bronchopulmonary dysplasia: Autoabstract of Diss. Voronezh, 2015. (in Russian)
32. Starevskaya S.V. The role of bronchoscopy in the comprehensive examination and treatment of children with lung diseases complicated by respiratory failure: Autoabstact of Diss. Saint Petersburg, 2016. (in Russian)
33. Davydova IV Organization course and outcomes of bronchopulmonary dysplasia in children: Autoabstract of Diss. Moscow, 2010. (in Russian)
34. Zatolokina A.O., Belousova T.V., Loskutova S.A., Andriushina I.V. Outcomes bronchopulmonary dysplasia in children in the Novosibirsk region. Mat’ i ditya [Mother and Child]. 2016; 3 (66): 9-14. (in Russian)
35. Unal S., Kaya A., Bilgin L., et al. Wheezing, asthma, and atopy in premature infants at 2 years of age. Med Sci. 2017; 47 (2): 607-13.
36. Ng D.K., Lau W.Y., Lee S.L. Pulmonary sequelae in long-term survivors of bronchopulmonary dysplasia. Pediatr Int. 2000; 42: 603-7.
37. Evans M., Palta M., Sadek M., et al. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am J Epidemiol. 1998; 148: 460-6.
38. Sofronova L.N., Fedorova L.A., Kyanksep A.N., et al. Late preterm -a group of high risk of early and distant complications. Pediatriya [Pediatrics]. 2018; 1 (97): 131-40. (in Russian)
39. Guimaraes H., Rocha G., Pissara S., et al. Respiratory outcomes and atopy in school-age children who were preterm at birth, with and without bronchopulmonary dysplasia. Clinics. 2011; 66: 425-30.
40. Kaplan E., Bar-Yishay E., Prais D., et al. Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the post-surfactant era. Chest. 2012; 142: 725-33.
41. Bousquet J., Khaltaev N., Cruz A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy. 2008; 63 (86): 8-160.
42. National program: "Bronchial asthma in children. Treatment and Prevention Strategy". 2th ed. Moscow: Russkiy vrach, 2006: 100 p. (in Russian)
43. Federal clinical guidelines for the management of children with bronchopulmonary dysplasia, 2014. URL: https://minzdrav.gov-murman.ru/ documents/poryadki-okazaniya-meditsinskoy-pomoshchi/_kr_bld.pdf (date of access June 29, 2019)
44. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008; 8 (3): 183-92.
45. Hay D.W. Pharmacology of leukotriene receptor antagonists. Chest. 1997; 111 (2 suppl): 35S-45S.
46. Szefler S., Carlsson L.G., Szefler T.U., et al. Budesonide inhalation suspension versus Montelukast in children aged 2 to 4 years with mild persistent asthma. J Allergy Clin Immunol. 2013; 1: 58-64.
47. Castro-Rodriguez J.A., Rodrigo G.J. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Arch Dis Child. 2010; 95: 365-70.
48. Meer S., Groothuis J.R., Harbeck R., et al. The potential role of gastroesophageal reflux in the pathogenesis of food-induced wheezing. Pediatr Allergy Immunol. 1996; 7: 167-70.
49. Yang J.Y., Cha J., Shim S.-Y., et al. The relationship between eosino-philia and bronchopulmonary dysplasia in premature infants at less than 34 weeks’ gestation. Korean J Pediatr. 2014; 57 (4): 171-7
50. Yen J.-M., Lin C.-H., Yang M.-M. Eosinophilia in very low birth weight infants. Pediatr Neonatol. 2010; 51 (2): 116-23.
51. Korzhenkova M.P. Clinical characteristics and some issues of the pathogenesis of acute respiratory diseases in children in the first year of life: Autoabstract of Diss. Moscow, 1969. (in Russian)
52. Yakovleva N.V. Respiratory viruses. Mechanisms of inflammation of the bronchi and lungs and anti-inflammatory therapy. Saint Petersburg: Nordmed-Izdat, 1998: 66 p. (in Russian)
53. Boytsova E.V., Titova O.N., Ovsyannikov D.Yu., Bogdanova A.V. Respiratory outcomes of bronchopulmonary dysplasia in children, adolescents and adults. Pul’monologiya [Pulmonology]. 2017; 27 (1): 87-96. (in Russian)